EL
EL.PA EssilorLuxottica S. A.
- Market cap
- EUR 88.8B
- P/E
- 36.2x
- P/B
- 2.27x
- ROE
- 16.0%
- Dividend yield
- 0.62%
- Fundamental score
- 2.8/5
Ratios use the latest price and the current fiscal year annualized from 1 quarter up to Jun 2026.
Is EL.PA undervalued?
Graham numberEL.PA trades 91.0% above its Graham number.
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
EssilorLuxottica S. A. fundamental analysis
9 of 11 checks passedROE 1/2
ROE in an average range (4.04%) suggests satisfactory profitability and decent utilization of shareholders' equity.
ROA 1/2
The stock's ROA (6.24%) shows that it's doing a pretty good job at making money from its assets, making it a solid choice to invest and earn steady profits.
PBV 1/2
The stock's PBV ratio (2.09x) indicates a justifiable valuation, presenting a compelling choice for investors seeking reasonable returns.
DER 2/2
The stock has a minimal amount of debt (31%) relative to its ownership, showcasing a strong financial position and lower risk for investors.
Revenue Growth 1/2
Over the past three years, this company's revenue has consistently grown, demonstrating a positive financial trend that makes it an appealing choice.
Net Profit Growth 1/2
This company's net profit has consistently grown over the past three years, showcasing a positive financial trend and making it an appealing investment opportunity.
Assets Growth 0/2
Company's revenue has remained stagnant over the past three years, indicating a lack of growth and making it a less favorable option.
Graham Number 0/1
The Graham number of this company suggests that its stock price may be overvalued, indicating a less favorable investment opportunity.
Dividend Growth 1/2
The company's dividend growth has exhibited a remarkable upward trend over the past three years, consistently delivering higher payouts to shareholders.
Dividend 2/2
Shareholders can rely on the company's remarkable dividend history, consistently paying dividends for the past five years, demonstrating a steadfast dedication to rewarding investors.
Buffet Intrinsic Value 1/1
Warren Buffett's formula suggests that the company's stock is undervalued (5.737), making it an appealing investment prospect with its intrinsic value surpassing the current market price.
Each check is worth 1 or 2 points by how much it says about the quality of the company. The score is the share of points earned, out of 5. Ask AI to explain this score
EssilorLuxottica S. A. stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About EssilorLuxottica S. A.
EssilorLuxottica Société anonyme designs, manufactures, and distributes ophthalmic lenses, frames, sunglasses, and instruments and equipment in North America, the Middle East, Africa, Europe, Latin America, and the Asia-Pacific. It offers lens, eyewear, contact lenses, reading glasses under Essilor, Varilux, Crizal, Eyezen, Stellest, Xperio, Transitions, Ray-Ban, Oakley, Barberini, KODAK Lens, Nikon, Shamir Optical, eyexpert, iWear, Humanware, Optifog, Persol, Oliver Peoples…
Full company profileEssilorLuxottica S. A. financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 1 quarter up to Jun 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
EssilorLuxottica S. A. annual financial statements
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 7.12B | 9.18B | 10.8B | 17.4B | 14.4B | 19.8B | 24.5B | 25.4B | 26.5B | 28.5B | 59.3B |
| Gross Profit | 4.18B | 5.86B | 6.74B | 10.8B | 8.49B | 12.3B | 15.6B | 16.0B | 16.8B | 17.3B | 37.6B |
| Operating Income | 1.27B | 1.67B | 1.51B | 2.09B | 719M | 2.57B | 3.26B | 3.18B | 3.45B | 3.45B | 9.01B |
| EBITDA | 1.72B | 2.21B | 2.62B | 3.82B | 2.61B | 4.71B | 6.10B | 6.21B | 6.55B | 6.54B | 15.4B |
| Net Income | 813M | 789M | 1.08B | 1.08B | 85.0M | 1.45B | 2.15B | 2.29B | 2.36B | 2.32B | 6.26B |
| EPS | 3.71 | 3.58 | 4.07 | 2.44 | 0.19 | 3.25 | 4.83 | 5.08 | 5.13 | 4.98 | 13 |
| Balance Sheet | |||||||||||
| Total Assets | 13.2B | 10.1B | 48.4B | 52.6B | 52.3B | 59.4B | 60.6B | 60.5B | 64.3B | 63.9B | 65.1B |
| Total Liabilities | 6.11B | 4.25B | 15.0B | 17.3B | 19.5B | 23.5B | 22.4B | 21.6B | 23.3B | 24.4B | 25.1B |
| Shareholders' Equity | 6.69B | 5.81B | 32.9B | 34.8B | 32.3B | 35.1B | 37.5B | 38.2B | 40.4B | 38.9B | 39.2B |
| Cash & Short-term Investments | 517M | 1.17B | 1.84B | 5.38B | 8.93B | 3.34B | 1.99B | 2.56B | 2.25B | 3.54B | 1.93B |
| Total Debt | 2.61B | 1.90B | 5.70B | 9.42B | 11.9B | 13.0B | 12.2B | 11.7B | 13.2B | 14.4B | 15.3B |
| Cash Flow | |||||||||||
| Operating Cash Flow | 1.19B | 1.60B | 2.36B | 3.30B | 2.95B | 4.55B | 4.78B | 4.86B | 4.87B | 5.29B | 8.68B |
| Capital Expenditure | 294M | 664M | 710M | 903M | 650M | 1.03B | 1.57B | 1.53B | 1.52B | 1.53B | 2.59B |
| Free Cash Flow | 900M | 939M | 1.65B | 2.40B | 2.30B | 3.52B | 3.21B | 3.33B | 3.35B | 3.77B | 6.09B |
| Ratios | |||||||||||
| ROE | 12.2% | 13.6% | 3.3% | 3.1% | 0.3% | 4.1% | 5.7% | 6.0% | 5.8% | 6.0% | 16.0% |
| ROA | 6.2% | 7.8% | 2.2% | 2.0% | 0.2% | 2.4% | 3.6% | 3.8% | 3.7% | 3.6% | 9.6% |
| Net Profit Margin | 11.4% | 8.6% | 10.0% | 6.2% | 0.6% | 7.3% | 8.8% | 9.0% | 8.9% | 8.1% | 10.6% |
| Debt to Equity | 0.39x | 0.33x | 0.17x | 0.27x | 0.37x | 0.37x | 0.33x | 0.30x | 0.33x | 0.37x | 0.39x |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
EssilorLuxottica S. A. dividends
- Dividend yield
- 0.62%
- Forward dividend
- 4.00 EUR
- Payout ratio
- 23.6%
- Ex-dividend date
- May 5, 2026
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | EUR 547M | 1.18 | 23.6% |
| 2024 | EUR 1.16B | 2.53 | 49.3% |
| 2023 | EUR 487M | 1.08 | 21.3% |
| 2022 | EUR 454M | 1.02 | 21.1% |
| 2021 | EUR 138M | 0.31 | 9.5% |
| 2020 | EUR 503M | 1.15 | 591.8% |
| 2019 | EUR 887M | 2.01 | 82.4% |
| 2018 | EUR 484M | 1.82 | 44.7% |
| 2017 | EUR 440M | 1.99 | 55.8% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Last stock split: 2:1 on Jul 16, 2007.
Who owns EssilorLuxottica S. A.
- Insiders 36.99%
- Institutions 27.63%
- Public & others 35.38%
- Shares outstanding 458M
- Free float 275M
EssilorLuxottica S. A. company profile
- Company name
- EssilorLuxottica S. A.
- Ticker
- EL.PA
- ISIN
- FR0000121667
- Exchange
- Euronext Paris
- Sector
- Healthcare
- Industry
- Health Care Equipment & Supplies
- Employees
- 213,909
- Fiscal year end
- December
- Address
- 1-5 rue Paul Cézanne, Paris, France, 75008
- Phone
- 33 1 49 77 42 24
- Website
- essilorluxottica.com
About EssilorLuxottica S. A.
EssilorLuxottica Société anonyme designs, manufactures, and distributes ophthalmic lenses, frames, sunglasses, and instruments and equipment in North America, the Middle East, Africa, Europe, Latin America, and the Asia-Pacific. It offers lens, eyewear, contact lenses, reading glasses under Essilor, Varilux, Crizal, Eyezen, Stellest, Xperio, Transitions, Ray-Ban, Oakley, Barberini, KODAK Lens, Nikon, Shamir Optical, eyexpert, iWear, Humanware, Optifog, Persol, Oliver Peoples, Vogue Eyewear, Arnette, Alain Mikli, Costa, Bliz, Native Eyewear and Bolon, and Foster Grant brands. The company also provides vision assessment, eye pathology diagnosis and treatment, finishing equipment, fitting parameter measurement, small tools, and consumables. In addition, it offers SPECTRALIS, a multimodal imaging platform for diagnosis and treatment; RetinAI; Espansione Group; Cellview Imaging; ANTERION, a multidisciplinary all-in-one anterior segment imaging solution for measurements; apparel, footwear and accessories; and high-tech equipment for optical surfacing, polishing, measuring, coating, and finishing, as well as consumables, tools, and services under the Satisloh brand. Further, the company designs, develops, markets, and maintains diagnostics, refraction, lens edging and mounting instruments for opticians and prescription laboratories, and measurement; and optometry instruments for eyecare professionals, schools, occupational medicine centers, military, and other institutions. It sells its products to independent opticians, distributors, third-party e-commerce platforms, and large retail chains in the eyecare and eyewear industry; and consumers through the network of brick and mortar retail networks and its online channels. The company was formerly known as Essilor International Société Anonyme and changed its name to EssilorLuxottica Société anonyme in October 2018. EssilorLuxottica Société anonyme was founded in 1849 and is headquartered in Paris, France.
EssilorLuxottica S. A. management
7- Mr. Francesco MilleriNon-Independent Chairman & CEO · born 1959
- Mr. Paul du SaillantDeputy CEO & Non-Independent Director · born 1959
- Mr. Stefano GrassiChief Financial Officer · born 1973
- Giorgio IannellaHead of Investor Relations
- Mr. Marco CatalaniHead of Corporate Communications
- Mr. Ambati VenuPresident- Greater India · born 1969
- Mr. Ashwin UppalHead of Marketing, Greater India